key: cord-0759521-bo41oybu
authors: Ustaoglu, Eda
title: The impact of COVID‐19 pandemic in dermatology outpatient clinics in Turkey: A survey study
date: 2021-06-25
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14297
sha: 27d922e8e9b10b72bee6224d0377eb1262afb5a0
doc_id: 759521
cord_uid: bo41oybu

BACKGROUND: The COVID‐19 pandemic has substantially affected the healthcare systems around the world. It has also induced some changes in working habits at dermatology clinics. The majority of dermatology clinics limited the number of patients at outpatient clinics and postponed the elective procedures. AIMS AND OBJECTIVES: To evaluate the working conditions and habits of dermatologists in Turkey during the COVID‐19 pandemic. METHODS: This is a survey study with seventeen questions in which two hundred fifteen dermatologists working in Turkey participated. RESULTS: Our results revealed that 53.5% of the participants worked in the areas related to COVID‐19 during the pandemic. The average number of dermatology outpatient days in a week was five among the 48.8% of dermatologists, 21.4% of those had three working days, and 18.1% of those had four days. During the pandemic, the most common reasons for referral to outpatient clinics were acne and acneiform eruptions (88.8%), dermatitis (73.5%), and hair loss (71.2%). Participants hesitated to use the following treatments: long‐term systemic steroid (77.7%), cyclosporine (69.8%), and methotrexate (60%). CONCLUSION: It is observed that the COVID‐19 pandemic had affected the working habits and conditions of the dermatologists, which might be considered for the designing of new working approaches.

| 2383 USTAOGLU 2 | MATERIAL AND ME THODS

This cross-sectional study was conducted in Bursa City Hospital, Bursa, Turkey, between November 2020 and February 2021, with the approval of the Local Ethics Committee (2020-11-13T10_43_20).

The survey forms were prepared using the Google Survey program and included 17 questions. The survey forms were distributed via social media groups and e-mail accounts. The questions had multiple choices, and some of those were able to be marked with more than one option. The categories of the questions were as follows:

the demographic characteristics of dermatologists, departments worked in the COVID-19 pandemic, the adaptations to COVID-19 regulations at the dermatology outpatient clinics, the common diseases observed during this period, the interventional procedures, the medical and laser treatments, and patient's compliance with the regulations. Participants who filled out the informed consent were able to fill the questionnaire.

Descriptive statistics for categorical variables were given as fre- 

This survey study shows that 53.5% of dermatologists in Turkey were actively involved in areas related to COVID-19, in addition to In our study, the most common reasons for referral to dermatology outpatient clinics were acne, dermatitis, hair loss, and scabies. The diseases frequency of which increased during the pandemic were dermatitis, acne, scabies, and urticaria. Acne, urticaria, and scabies were reported as the most common diagnoses for admission to the outpatient clinics in the first ten days following the COVID-19 pandemic in the study of Kutlu et al. 9 In this study, the authors also stated that although the total number of patients It has been stated that hair diseases such as alopecia areata and telogen effluvium increased during the pandemic period.

with COVID-19 infection may be effective in this increase. [12] [13] [14] In an online survey study conducted in patients with alopecia areata, telogen effluvium, and seborrheic dermatitis, it was shown that although telogen effluvium increased more during the pandemic period, people in these three disease groups admitted to outpatient clinics in less frequency during the pandemic period compared to the pre-period. 15 In our study, dermatologists stated that patients'

admissions with the complaint of hair loss increased. Patients' hesitation to enter the hospital environment during the pandemic and stay-at-home policies may have affected the patients' visits to the doctor. We think that hair loss may be a more frequent complaint than observed in outpatient clinics, and this increase may be seen in the future.

In a study conducted in Turkey, it was reported that scabies increased during the pandemic, the rates of which increased more at month three compared to month one following the first case of COVID-19. 16 It is thought that domestic transmission due to staying at home policy also contributed to this result. In another study conducted in Spain, the increase in scabies cases during the pandemic period was related to the home confinement policy. 17 It delayed admission to the hospital until symptoms become evident. It has also been stated that domestic transmission might have had a role in the increase of it.

During the pandemic, it has been shown that the number of patients referred to dermatology outpatient clinics decreased compared to the pre-pandemic period. 9, 18 In our study, 41.9% of dermatologists stated that they examined 20 to 40 patients in a day, and 22.3% of those examined 40 to 60 patients in a day.

The mask using rates were 89.3% for surgical masks and 53.1%

for FFP2/FFP3. In a study conducted in India with 260 dermatologists, 54% of the participants reported that they felt panic, anxiety, and fear due to the pandemic; 50.7% of those thought that their health systems were not equipped to cope with the pandemic. 19 As dermatological examination includes face, lips, oral mucosa, and nasal examinations, it has been more critical to protect dermatologists during the pandemic period. In our study, the examinations that made the dermatologists unsafe were oral mucosa, lips, and nose examinations, respectively. The effective personal protective equipment usage by dermatologists and the level of knowledge and awareness of patients with using masks and social distance compliance can be effective in making them feel safe in outpatients' clinics.

In a study conducted in the United States, it was reported that the number of working days and the average number of skin biopsies requested from patients decreased, and non-urgent appointments were postponed during the pandemic. 7 In our study, we found that participants did not feel safe during dermatoscopic examination (38.6%) and dermo-cosmetic applications (37.7%) mostly. On the contrary, 29.3% of the participants stated that the pandemic had no effect on their practices. The rate of dermatologists hesitating to perform a skin biopsy, excision, and curettage was 20%. Because of the need to be close to the patient for dermatoscopic examination, there is concern that this practice might have a role in increasing Older age and accompanying comorbidities may pose a risk for infection regardless of the immunosuppressive/immunomodulatory agents used in the treatment of psoriasis patients. 23 In a study conducted in Italy, no significant increase in hospitalization and mortality rates was observed in psoriasis patients using biological agents. 24 The fact that these patients had comorbidities such as obesity, cardiovascular diseases, diabetes, and hypertension made this result more meaningful. Our study shows that dermatologists considered biological agents safer than long-term systemic steroids, methotrexate, cyclosporine, and azathioprine. A case-based approach is recommended with careful use of these agents, giving priority to alternative therapies and evaluating accompanying comorbidities, especially in risky areas where many cases are present. [21] [22] [23] In conclusion, the COVID-19 pandemic has dramatically affected dermatology practice. In Turkey, dermatologists have been working in areas related to COVID-19, in addition to their work at dermatology outpatient clinics. Identifying the impact of the pandemic on dermatologists will contribute to more predictable management of this approach.

The author declares no conflict of interest.

SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options

WHO declares COVID-19 a pandemic

Fair allocation of scarce medical resources in the time of covid-19

What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?

Impact of COVID-19 outbreak on dermatology services: dermatology in isolation

Global coronavirus pandemic (2019-nCOV): implication for an Italian medium size dermatological clinic of a II level hospital

The immediate impact of COVID-19 on US dermatology practices

Impact of the COVID-19 pandemic on dermatology practice worldwide: results of a survey promoted by the International dermoscopy society (IDS)

The effect of the "stay-at-home" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak

Optimizing care for atopic dermatitis patients during the COVID-19 pandemic

Relationship between hand hygiene and cutaneous findings during COVID-19 pandemic

Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic

Telogen effluvium associated with COVID-19 infection

SARS-CoV-2-induced telogen effluvium: a multicentric study

Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire

Comparison of patients' diagnoses in a dermatology outpatient clinic during the COVID-19 pandemic period and pre-pandemic period

Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic

Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice

Impact of COVID-19 pandemic on dermatology practice in India

Medical and socioeconomic challenges of private dermatocosmetology clinics during COVID-19 pandemic: A survey from Turkey

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Impact of the COVID-19 pandemic on immunomodulatory and immunosuppressive therapies in dermatology: patient and physician attitudes in Argentina

COVID-19 and psoriasis: should we fear for patients treated with biologics?

The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

The approval of Local Ethics Committee was obtained for this study.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0003-0972-4673